Navigation Links
Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program
Date:9/3/2008

- Long term follow up results from chronically infected Hepatitis C patients strongly confirm and exceed positive data obtained earlier in 2008 - Study is the first to show a statistically significant and long-term

antiviral effect of therapeutic Hepatitis C vaccination - Data pave the way and strongly support move into a second generation vaccine formulated with Intercell's adjuvant IC31(R) acting through TLR

activation

VIENNA, Austria, Sept. 3 /PRNewswire/ -- Today, Intercell AG (ICLL) announced the six months follow up data of its exploratory clinical Phase II study targeting treatment-naive Hepatitis C genotype-1 patients. As previously reported in February 2008, in this trial the therapeutic Hepatitis C vaccine (IC41) comprising five synthetic T-cell peptides and Intercell's first-generation poly-Arginine adjuvant (IC30) disclosed a statistically significant reduction of viral load in the blood of chronically infected patients up to 2 weeks after the last vaccination. The current long term follow up results show that this reduction was significantly more pronounced at six months after the final vaccination.

In the open label controlled multicenter Phase II study 50 genotype-1 patients, naive to standard treatment were enrolled for receiving a treatment schedule consisting of 8 intra-dermal IC41 vaccinations in biweekly intervals with topical application of the Toll-like receptor (TLR) agonist imiquimod. The previous analysis of 46 patients at 2 weeks after the last vaccination with IC41 showed already a statistically significant (p=0.001) HCV RNA decline of 0.2 log. The present follow-up data from 33 patients at six months after end of IC41 vaccination revealed an even greater viral load decline of 0.46 log (p=0.001). Interestingly, the virus decline (0.6 log) at the six months time point was most pronounced in patients with high initial viral load (> 2 million copies/ml). A parallel st
'/>"/>

SOURCE Intercell AG
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
2. FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
3. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
4. Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months
5. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
6. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
7. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
8. IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
9. Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinsons Disease
10. Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
11. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...INGTON, Va., Dec. 1 BioInformatics... The Market Outlook for Research Products in FY20...NIH Scientific Research program by the American Re...ked for lab renovations, Challenge Grants, the Sha...s multiple public and non-profit institutions, all...
(Date:12/1/2009)... Va., Dec. 1 CEL-SCI Cor... company and a developer of vaccines and therapeut... diseases, announced today that it has retained th...rganization (CRO) to run CEL-SCI,s upcoming Phase ...ck cancer with the Company,s lead product candidat...
(Date:12/1/2009)...RNIE, Md., Dec. 1 Sleep Solutions&...provider for home testing and evaluation of sleep-... Richard Hassett, M.D., as its chief executive off...ia Healthcare, during its growth from a $250 milli...industry leader in total population health, and it...
Breaking Medicine Technology:BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 2BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 3CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3Protein linked to mental retardation controls synapse maturation plasticity CSHL team finds 8676 1Protein linked to mental retardation controls synapse maturation plasticity CSHL team finds 8676 2Protein linked to mental retardation controls synapse maturation plasticity CSHL team finds 8676 3John Hancock Launches New Retirement Income Solution 47481 1John Hancock Launches New Retirement Income Solution 47481 2John Hancock Launches New Retirement Income Solution 47481 3John Hancock Launches New Retirement Income Solution 47481 4John Hancock Launches New Retirement Income Solution 47481 5Explorers Bounty Coffees and Chocolates Helping Individuals Reverse the Aging Process 47478 1Explorers Bounty Coffees and Chocolates Helping Individuals Reverse the Aging Process 47478 2
...7 Grammy Winner Marc Cohn, best,known for the hit...and,talents to the challenge of AIDS in Africa by ...n Cary on September 30th. Cohn will be joined in,t... the Wet Sprocket),Derek Webb, and local favorites...peFest, which benefits Beacon of Hope in Nairobi, ...
...ept. 17 Terumo Heart, Inc. announced,today that i...e European,Association of Cardio-Thoracic Surgeons...ttp://www.newscom.com/cgi-bin/prnh/20061027/DEF004...nh/20070227/CLTU043LOGO ) A summary of the Europ...eft Ventricular Assist System (LVAS) was presented...
Other Medicine Technology:Grammy Winner Marc Cohn to Perform for African AIDS Organization at Carolina HopeFest 2Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results 2
(Date:12/1/2009)... Could identify those who would benefit from live... TUESDAY, Dec. 1 (HealthDay News) -- A CT scan of ...ncer may help predict overall survival after chemo...ab (Avastin) to cytotoxic chemotherapy has been sh...e colorectal cancer and to produce better results ...
(Date:12/1/2009)... , Practitioners of any m...transcription are breathing a sigh of relief this ...e iPhone. The application, released over the holi... transcribe voice recordings to do so quickly and ... (PRWEB) December 1, 2009 -- T...
(Date:12/1/2009)... , , ,, NEW YORK, Dec. 1...th and a global leader in the development and deli...on for the medical, scientific and academic market...Universal Search, our first-to-market cross-platfo...w psychology lexicon, based on the American Psycho...
(Date:12/1/2009)... , , FORT LAUDERDALE, Fla., Dec. 1 /PRN...ion of patient enrollment in the randomized clinic...ting Stent (Combo Stent). ,, A prospective, ran...d E valuation of an ablu M inal sirolimus coa...180 patients at up to 20 sites in Asia, Australia,...
(Date:12/1/2009)... , Montreal, December 1, 2009 A Universit de Mon...esearch Center on Family Violence and Violence Aga...e effects of pornography on men. "We started our r...r consumed pornography. We couldn,t find any," say...nd professor at the School of Social Work. , "T...
Breaking Medicine News(10 mins):Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Are the effects of pornography negligible? 2
... The reported failure of vitamin E to prevent hear...a new study by investigators at Vanderbilt Univers...rly online in Free Radical Biology and Medicine, s...studies have ever conclusively demonstrated the do...
...vented buildup of dangerous tau protein , ...esigned to combat a protein implicated in Alzheime...entists say. , Abnormal tau protein accumulates in...ver, the new NYUMC-developed vaccine prevented tau...
...f cases went unnoticed, study found , , TU...d only one in four children who had high blood pre... the dangerous problem is missed. , "Hypertension ...logy Leadership at Harvard Medical School. , In a ...
...ventions are highly effective in preventing the be...ention Deficit Hyperactivity Disorder (ADHD), acco...ehigh Universitys College of Education. , The stu...who have shown significant symptoms of ADHD. It al...
... boosted drugs, killing power 6-fold , , T... glass of cranberry juice might greatly boost an o...y, a new study suggests. , In laboratory experimen... that the finding is still experimental and prelim...
... WASHINGTON, DC) A coalition of physicians repres...ued a call to action to improve the treatment of s...ized leaders in neurology, neuroradiology, neurosu...he most pressing medical needs in this countrythe ...
Other Medicine News:Health News:Vitamin E's lack of heart benefit linked to dosage 2Health News:Vitamin E's lack of heart benefit linked to dosage 3Health News:Doctors Often Miss High Blood Pressure in Kids 2Health News:Doctors Often Miss High Blood Pressure in Kids 3Health News:Non-medicinal treatment touted for pre-schoolers with ADHD 2Health News:Non-medicinal treatment touted for pre-schoolers with ADHD 3Health News:Cranberry Could Juice Up Ovarian Cancer Treatment 2Health News:Cranberry Could Juice Up Ovarian Cancer Treatment 3Health News:Broad-based group of physicians calls for improvement in stroke treatment 2Health News:Broad-based group of physicians calls for improvement in stroke treatment 3
Single-Piece PMMA
STABIBAG Hydrophilic Acrylic Lens
BIGBAG Hydrophilic Acrylic Lens
MF4 MULTIFOCAL LENS
Medicine Products: